GIPC1 and cancer: Following the results obtained with different cancer cell lines, we have extended our study by further analysis of 27.B1 and 27.F7 antibodies interaction with different types of malignant and benign breast tumors in order to evaluate the incidence of GIPC1 enhanced expression within a given tumor type and to compare GIPC1 expression in different breast tumor types.